Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Mechanical Intervention for Acute Myocardial Infarction

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 3, 2005-07 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Glycoprotein IIb/IIIa Receptor Inhibitor on the Microcirculation in Patients Undergoing High-Risk Coronary Stenting; A Prospective, Randomized Study

By Wong Philip   Harding Scott   Inglessis Ignacio   Choi C. Joon   Walters Darren   Chang Yuchiao   Gimelli Giogio   Jang Ik-Kyung  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 163-166

Springer Publishing Company

Access to resources Recommend Favorite

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

By  

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

Update on Glycoprotein IIb/IIIa: Role in Primary Coronary Intervention

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 2, 2011-01 ,pp. : 106-112

Bentham Science Publishers

Access to resources Recommend Favorite

Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase

By Meyners W.  

Zeitschrift für Kardiologie, Vol. 93, Iss. 5, 2004-05 ,pp. : 407-412

Springer Publishing Company

Access to resources Recommend Favorite